EUVIMEDEUVIMED entdecken
Crossref

A Novel CaCu‐Metal–Organic‐Framework Based Multimodal Treatment Platform for Enhanced Synergistic Therapy of Hepatocellular Carcinoma

Weijun Chen, Meiyang Yang, Huili Wang, Junling Song, Congjin Mei, Lipeng Qiu iD, Jinghua Chen

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202304000 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Weijun Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences and Health Engineering, Jiangnan University, Wuxi, 214122, China. Hauptthemen laut MEDLINE: Doxorubicin, Metal-Organic Frameworks, Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metal ions have attracted a lot of interest in antitumor therapy due to their unique mechanism of action. However, multiple death mechanisms associate with metal ions to synergistic antitumors have few studies mainly due to the serious challenges in designing and building metal‐associated multimodal treatment platforms. Hence, a series of glutathione‐activatable CaCu‐based metal–organic‐frameworks loaded with doxorubicin and ovalbumin are successfully designed and synthesized with an “all in one” strategy, which is modified by galactosamine‐linked hyaluronic acid to prepare multimodal treatment platform (SCC/DOX@OVA‐HG) for targeted delivery and synergistic antitumor therapy. SCC/DOX@OVA‐HG can be rapidly degraded by the overexpressed glutathione and then releases the “cargoes” in the tumor microenvironment. The released Cu + efficiently catalyzes H 2 O 2 to produce highly toxic ROS for CDT, and the up‐regulation of calcium ion concentration in tumor cells induced by the released Ca 2+ enables calcium overload therapy, which synergically enhances the metal‐related death pattern. Meanwhile, OVA combined with Ca 2+ /Cu 2+ further activates macrophages into an M1‐like phenotype to accelerate tumor cell death through immunotherapy. Besides, the released DOX can also insert into the DNA double helix for chemotherapy. Consequently, the developed SCC/DOX@OVA‐HG reveals significantly improved antitumor efficacy through a multimodal synergistic therapy of chemotherapy, chemodynamic therapy, calcium overload, and immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinMetal-Organic FrameworksLiver NeoplasmsCarcinoma, HepatocellularAnimalsMiceHumansCell Line, TumorOvalbuminCopperHyaluronic AcidTumor Microenvironment

Stichwörter der Autor:innen

GSH‐activatablebimetal‐related therapymetal–organic frameworks (MOFs)multimodal treatment platform

Substanzen

DoxorubicinMetal-Organic FrameworksOvalbuminCopperHyaluronic Acid

Autor:innen und Institutionen

  • School of Life Sciences and Health Engineering, Jiangnan University, Wuxi, 214122, China.
  • School of Chemical and Material Engineering, Jiangnan University, Wuxi, 214122, China.
  • College of Chemistry and Molecular Sciences, Wuhan University, Wuhan, 430072, China.

ORCID-Profile: Lipeng Qiu

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Chen, W., Yang, M., Wang, H., Song, J., Mei, C., Qiu, L., & Chen, J. (2024). A Novel CaCu‐Metal–Organic‐Framework Based Multimodal Treatment Platform for Enhanced Synergistic Therapy of Hepatocellular Carcinoma. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202304000

Vancouver

Chen W, Yang M, Wang H, Song J, Mei C, Qiu L, et al. A Novel CaCu‐Metal–Organic‐Framework Based Multimodal Treatment Platform for Enhanced Synergistic Therapy of Hepatocellular Carcinoma. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202304000

BibTeX
@article{Chen2024,
  author = {Chen, Weijun and Yang, Meiyang and Wang, Huili and Song, Junling and Mei, Congjin and Qiu, Lipeng and Chen, Jinghua},
  title = {A Novel CaCu‐Metal–Organic‐Framework Based Multimodal Treatment Platform for Enhanced Synergistic Therapy of Hepatocellular Carcinoma},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202304000}
}
Kostenlos starten →